When.com Web Search

  1. Ads

    related to: nose massage before and after hot flashes treatment options for men

Search results

  1. Results From The WOW.Com Content Network
  2. Hot flashes: Here's what's causing them and ways to help ...

    www.aol.com/lifestyle/hot-flashes-heres-whats...

    Keep in mind that treating men for hot flashes may be different from treating women for hot flashes, especially if hot flashes are related to prostate cancer treatment.

  3. Hot flash - Wikipedia

    en.wikipedia.org/wiki/Hot_flash

    Research on hot flashes is mostly focused on treatment options. The exact cause and pathogenesis, or causes, of vasomotor symptoms (VMS)—the clinical name for hot flashes—has not yet been fully studied. [11] [12] Hot flashes are associated with declining levels of estrogen (estrogen withdrawal) and other hormonal changes. [13]

  4. Rhinophyma - Wikipedia

    en.wikipedia.org/wiki/Rhinophyma

    Operative treatment of rhinophyma, before and after. Treatment consists of paring down the bulk of the tissue with a sharp instrument or carbon dioxide laser and allowing the area to re-epithelialise. Sometimes, the tissue is completely excised and the raw area skin-grafted. [7]

  5. 9 types of food that provide comfort during hot flashes - AOL

    www.aol.com/9-types-food-comfort-during...

    Hot flashes—officially called vasomotor menopausal symptoms—come on with little warning. These scorching power surges can keep you up at night (the dreaded night sweats), leaving you and your ...

  6. Expert tips and top products to stop a hot flash, fast - AOL

    www.aol.com/lifestyle/how-to-stop-a-hot-flash...

    Hot flashes occur in around 80% of menopausal women and can include periods of sweating, flushing and chills lasting for several minutes. We've taken a deep dive into all things hot flashes to ...

  7. Side effects of bicalutamide - Wikipedia

    en.wikipedia.org/wiki/Side_effects_of_bicalutamide

    In the EPC trial, in which bicalutamide monotherapy (150 mg/day) was evaluated for treatment of early prostate cancer in 8,113 men, the incidence of abnormal liver function tests at 3-year median follow-up was 3.4% for bicalutamide plus standard care (n=4,052) and 1.9% for standard care alone (n=4,061).